Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 345

1.

A small-molecule ligand of valosin-containing protein/p97 inhibits cancer cell-accelerated fibroblast migration.

Suvarna K, Honda K, Muroi M, Kondoh Y, Osada H, Watanabe N.

J Biol Chem. 2019 Jan 4. pii: jbc.RA118.004741. doi: 10.1074/jbc.RA118.004741. [Epub ahead of print]

2.

Pharmacological management of progressive-fibrosing interstitial lung diseases: a review of the current evidence.

Richeldi L, Varone F, Bergna M, de Andrade J, Falk J, Hallowell R, Jouneau S, Kondoh Y, Morrow L, Randerath W, Strek M, Tabaj G.

Eur Respir Rev. 2018 Dec 21;27(150). pii: 180074. doi: 10.1183/16000617.0074-2018. Print 2018 Dec 31. Review.

3.

Proposed method of histological separation between connective tissue disease-associated interstitial pneumonia and idiopathic interstitial pneumonias.

Ozasa M, Ichikawa H, Sato S, Tanaka T, Johkoh T, Kataoka K, Yamano Y, Kondoh Y, Nakamura H, Kawakami A, Bychkov A, Taniguchi H, Fukuoka J.

PLoS One. 2018 Nov 5;13(11):e0206186. doi: 10.1371/journal.pone.0206186. eCollection 2018.

4.

Outcomes with newly proposed classification of acute respiratory deterioration in idiopathic pulmonary fibrosis.

Teramachi R, Kondoh Y, Kataoka K, Taniguchi H, Matsuda T, Kimura T, Yokoyama T, Yamano Y, Furukawa T, Sakamoto K, Hashimoto N, Hasegawa Y.

Respir Med. 2018 Oct;143:147-152. doi: 10.1016/j.rmed.2018.09.011. Epub 2018 Sep 13.

PMID:
30261987
5.

Ethnic differences in idiopathic pulmonary fibrosis: The Japanese perspective.

Saito S, Lasky JA, Hagiwara K, Kondoh Y.

Respir Investig. 2018 Sep;56(5):375-383. doi: 10.1016/j.resinv.2018.06.002. Epub 2018 Jul 27. Review.

PMID:
30061050
6.

Pleuroparenchymal fibroelastosis diagnosed by multidisciplinary discussions in Japan.

Ishii H, Watanabe K, Kushima H, Baba T, Watanabe S, Yamada Y, Arai T, Tsushima K, Kondoh Y, Nakamura Y, Terasaki Y, Hebisawa A, Johkoh T, Sakai F, Takemura T, Kawabata Y, Ogura T; Tokyo Diffuse Lung Disease Study Group.

Respir Med. 2018 Aug;141:190-197. doi: 10.1016/j.rmed.2018.06.022. Epub 2018 Jun 27.

PMID:
30053966
7.

Multidimensional improvement in connective tissue disease-associated interstitial lung disease: Two courses of pulse dose methylprednisolone followed by low-dose prednisone and tacrolimus.

Yamano Y, Taniguchi H, Kondoh Y, Ando M, Kataoka K, Furukawa T, Johkoh T, Fukuoka J, Sakamoto K, Hasegawa Y.

Respirology. 2018 Nov;23(11):1041-1048. doi: 10.1111/resp.13365. Epub 2018 Jul 16.

8.

Acute exacerbation of idiopathic pulmonary fibrosis triggered by Aspergillus empyema.

Suzuki A, Kimura T, Kataoka K, Matsuda T, Yokoyama T, Mori Y, Kondoh Y.

Respir Med Case Rep. 2018 Jan 31;23:103-106. doi: 10.1016/j.rmcr.2018.01.004. eCollection 2018.

9.

Clinical spectrum and prognostic factors of possible UIP pattern on high-resolution CT in patients who underwent surgical lung biopsy.

Kondoh Y, Taniguchi H, Kataoka K, Furukawa T, Shintani A, Fujisawa T, Suda T, Arita M, Baba T, Ichikado K, Inoue Y, Kishi K, Kishaba T, Nishiyama O, Ogura T, Tomii K, Homma S.

PLoS One. 2018 Mar 28;13(3):e0193608. doi: 10.1371/journal.pone.0193608. eCollection 2018.

10.

Performance of the St George's Respiratory Questionnaire in patients with connective tissue disease-associated interstitial lung disease.

Suzuki A, Kondoh Y, Swigris JJ, Ando M, Kimura T, Kataoka K, Yamano Y, Furukawa T, Numata M, Sakamoto K, Hasegawa Y.

Respirology. 2018 Mar 25. doi: 10.1111/resp.13293. [Epub ahead of print]

PMID:
29575410
11.

Respiratory failure patient with lung cancer diagnosed by transesophageal bronchoscopic ultrasound-guided aspirates.

Ito T, Oki M, Saka H, Kondoh Y, Kimura T, Kataoka K.

Respirol Case Rep. 2018 Feb 28;6(4):e00309. doi: 10.1002/rcr2.309. eCollection 2018 May.

12.
13.

Chemical array system, a platform to identify novel hepatitis B virus entry inhibitors targeting sodium taurocholate cotransporting polypeptide.

Kaneko M, Futamura Y, Tsukuda S, Kondoh Y, Sekine T, Hirano H, Fukano K, Ohashi H, Saso W, Morishita R, Matsunaga S, Kawai F, Ryo A, Park SY, Suzuki R, Aizaki H, Ohtani N, Sureau C, Wakita T, Osada H, Watashi K.

Sci Rep. 2018 Feb 9;8(1):2769. doi: 10.1038/s41598-018-20987-w.

14.

Identification of a small-molecule ligand of β-arrestin1 as an inhibitor of stromal fibroblast cell migration accelerated by cancer cells.

Suvarna K, Honda K, Kondoh Y, Osada H, Watanabe N.

Cancer Med. 2018 Mar;7(3):883-893. doi: 10.1002/cam4.1339. Epub 2018 Jan 29.

15.

A scoring system to predict the elevation of mean pulmonary arterial pressure in idiopathic pulmonary fibrosis.

Furukawa T, Kondoh Y, Taniguchi H, Yagi M, Matsuda T, Kimura T, Kataoka K, Johkoh T, Ando M, Hashimoto N, Sakamoto K, Hasegawa Y.

Eur Respir J. 2018 Jan 18;51(1). pii: 1701311. doi: 10.1183/13993003.01311-2017. Print 2018 Jan.

PMID:
29348178
16.

A Volumetric Computed Tomography Analysis of the Normal Lung in Idiopathic Pulmonary Fibrosis: The Relationship with the Survival.

Ohkubo H, Taniguchi H, Kondoh Y, Yagi M, Furukawa T, Johkoh T, Arakawa H, Fukuoka J, Niimi A.

Intern Med. 2018 Apr 1;57(7):929-937. doi: 10.2169/internalmedicine.9508-17. Epub 2017 Dec 21.

17.

Palliative care in interstitial lung disease: living well.

Kreuter M, Bendstrup E, Russell AM, Bajwah S, Lindell K, Adir Y, Brown CE, Calligaro G, Cassidy N, Corte TJ, Geissler K, Hassan AA, Johannson KA, Kairalla R, Kolb M, Kondoh Y, Quadrelli S, Swigris J, Udwadia Z, Wells A, Wijsenbeek M.

Lancet Respir Med. 2017 Dec;5(12):968-980. doi: 10.1016/S2213-2600(17)30383-1. Epub 2017 Oct 13. Review.

18.

Recent lessons learned in the management of acute exacerbation of idiopathic pulmonary fibrosis.

Kondoh Y, Cottin V, Brown KK.

Eur Respir Rev. 2017 Sep 27;26(145). pii: 170050. doi: 10.1183/16000617.0050-2017. Print 2017 Sep 30. Review. Erratum in: Eur Respir Rev. 2018 Apr 13;27(148):.

19.

Diagnostic accuracy of a clinical diagnosis of idiopathic pulmonary fibrosis: an international case-cohort study.

Walsh SLF, Maher TM, Kolb M, Poletti V, Nusser R, Richeldi L, Vancheri C, Wilsher ML, Antoniou KM, Behr J, Bendstrup E, Brown K, Calandriello L, Corte TJ, Cottin V, Crestani B, Flaherty K, Glaspole I, Grutters J, Inoue Y, Kokosi M, Kondoh Y, Kouranos V, Kreuter M, Johannson K, Judge E, Ley B, Margaritopoulos G, Martinez FJ, Molina-Molina M, Morais A, Nunes H, Raghu G, Ryerson CJ, Selman M, Spagnolo P, Taniguchi H, Tomassetti S, Valeyre D, Wijsenbeek M, Wuyts W, Hansell D, Wells A; IPF Project Consortium.

Eur Respir J. 2017 Aug 31;50(2). pii: 1700936. doi: 10.1183/13993003.00936-2017. Print 2017 Aug.

PMID:
28860269
20.

Disease severity staging system for idiopathic pulmonary fibrosis in Japan.

Kondoh Y, Taniguchi H, Kataoka K, Furukawa T, Ando M, Murotani K, Mishima M, Inoue Y, Ogura T, Bando M, Hagiwara K, Suda T, Chiba H, Takahashi H, Sugiyama Y, Homma S.

Respirology. 2017 Nov;22(8):1609-1614. doi: 10.1111/resp.13138. Epub 2017 Aug 8.

PMID:
28787101
21.

Treatment Rationale and Design for J-SONIC: A Randomized Study of Carboplatin Plus Nab-paclitaxel With or Without Nintedanib for Advanced Non-Small-cell Lung Cancer With Idiopathic Pulmonary Fibrosis.

Otsubo K, Kishimoto J, Kenmotsu H, Minegishi Y, Ichihara E, Shiraki A, Kato T, Atagi S, Horinouchi H, Ando M, Kondoh Y, Kusumoto M, Ichikado K, Yamamoto N, Nakanishi Y, Okamoto I.

Clin Lung Cancer. 2018 Jan;19(1):e5-e9. doi: 10.1016/j.cllc.2017.06.003. Epub 2017 Jun 20.

PMID:
28687482
22.

Depression Is Significantly Associated with the Health Status in Patients with Idiopathic Pulmonary Fibrosis.

Matsuda T, Taniguchi H, Ando M, Kondoh Y, Kimura T, Kataoka K, Nishimura K, Nishiyama O, Sakamoto K, Hasegawa Y.

Intern Med. 2017;56(13):1637-1644. doi: 10.2169/internalmedicine.56.7019. Epub 2017 Jul 1.

23.

Recent advances in connective tissue disease related interstitial lung disease.

Suzuki A, Kondoh Y, Fischer A.

Expert Rev Respir Med. 2017 Jul;11(7):591-603. doi: 10.1080/17476348.2017.1335600. Epub 2017 Jun 2.

PMID:
28544856
24.

CT-determined pulmonary artery to aorta ratio as a predictor of elevated pulmonary artery pressure and survival in idiopathic pulmonary fibrosis.

Yagi M, Taniguchi H, Kondoh Y, Ando M, Kimura T, Kataoka K, Furukawa T, Suzuki A, Johkoh T, Hasegawa Y.

Respirology. 2017 Oct;22(7):1393-1399. doi: 10.1111/resp.13066. Epub 2017 May 10.

PMID:
28488784
25.

Identification of a trichothecene production inhibitor by chemical array and library screening using trichodiene synthase as a target protein.

Maeda K, Nakajima Y, Motoyama T, Kondoh Y, Kawamura T, Kanamaru K, Ohsato S, Nishiuchi T, Yoshida M, Osada H, Kobayashi T, Kimura M.

Pestic Biochem Physiol. 2017 May;138:1-7. doi: 10.1016/j.pestbp.2017.03.006. Epub 2017 Mar 22.

PMID:
28456298
26.

Investigation of the inhibitory mechanism of apomorphine against MDM2-p53 interaction.

Ishiba H, Noguchi T, Shu K, Ohno H, Honda K, Kondoh Y, Osada H, Fujii N, Oishi S.

Bioorg Med Chem Lett. 2017 Jun 1;27(11):2571-2574. doi: 10.1016/j.bmcl.2017.03.082. Epub 2017 Mar 29.

PMID:
28400230
27.

Inhibition of CRM1-mediated nuclear export of influenza A nucleoprotein and nuclear export protein as a novel target for antiviral drug development.

Chutiwitoonchai N, Mano T, Kakisaka M, Sato H, Kondoh Y, Osada H, Kotani O, Yokoyama M, Sato H, Aida Y.

Virology. 2017 Jul;507:32-39. doi: 10.1016/j.virol.2017.04.001. Epub 2017 Apr 8.

28.

The clinical impact of major comorbidities on idiopathic pulmonary fibrosis.

Suzuki A, Kondoh Y.

Respir Investig. 2017 Mar;55(2):94-103. doi: 10.1016/j.resinv.2016.11.004. Epub 2017 Jan 14. Review.

PMID:
28274539
29.

Hemosiderin-laden macrophages are an independent factor correlated with pulmonary vascular resistance in idiopathic pulmonary fibrosis: a case control study.

Fukihara J, Taniguchi H, Ando M, Kondoh Y, Kimura T, Kataoka K, Furukawa T, Johkoh T, Fukuoka J, Sakamoto K, Hasegawa Y.

BMC Pulm Med. 2017 Feb 6;17(1):30. doi: 10.1186/s12890-017-0376-8.

30.

Progression of mean pulmonary arterial pressure in idiopathic pulmonary fibrosis with mild to moderate restriction.

Teramachi R, Taniguchi H, Kondoh Y, Ando M, Kimura T, Kataoka K, Suzuki A, Furukawa T, Sakamoto K, Hasegawa Y.

Respirology. 2017 Jul;22(5):986-990. doi: 10.1111/resp.12986. Epub 2017 Jan 24.

PMID:
28117530
31.

The St. George's Respiratory Questionnaire as a prognostic factor in IPF.

Furukawa T, Taniguchi H, Ando M, Kondoh Y, Kataoka K, Nishiyama O, Johkoh T, Fukuoka J, Sakamoto K, Hasegawa Y.

Respir Res. 2017 Jan 17;18(1):18. doi: 10.1186/s12931-017-0503-3.

32.

Synthesis of Grb2 SH2 Domain Proteins for Mirror-Image Screening Systems.

Noguchi T, Ishiba H, Honda K, Kondoh Y, Osada H, Ohno H, Fujii N, Oishi S.

Bioconjug Chem. 2017 Feb 15;28(2):609-619. doi: 10.1021/acs.bioconjchem.6b00692. Epub 2017 Jan 13.

PMID:
28032751
33.

Prognostic evaluation by oxygenation with positive end-expiratory pressure in acute exacerbation of idiopathic pulmonary fibrosis: A retrospective cohort study.

Suzuki A, Taniguchi H, Ando M, Kondoh Y, Kimura T, Kataoka K, Matsuda T, Yokoyama T, Sakamoto K, Hasegawa Y.

Clin Respir J. 2018 Mar;12(3):895-903. doi: 10.1111/crj.12602. Epub 2017 Jan 12.

PMID:
28026113
34.

The Japanese Respiratory Society Noninvasive Positive Pressure Ventilation (NPPV) Guidelines (second revised edition).

Akashiba T, Ishikawa Y, Ishihara H, Imanaka H, Ohi M, Ochiai R, Kasai T, Kimura K, Kondoh Y, Sakurai S, Shime N, Suzukawa M, Takegami M, Takeda S, Tasaka S, Taniguchi H, Chohnabayashi N, Chin K, Tsuboi T, Tomii K, Narui K, Hasegawa N, Hasegawa R, Ujike Y, Kubo K, Hasegawa Y, Momomura SI, Yamada Y, Yoshida M, Takekawa Y, Tachikawa R, Hamada S, Murase K.

Respir Investig. 2017 Jan;55(1):83-92. doi: 10.1016/j.resinv.2015.11.007. Epub 2016 Nov 9. No abstract available.

35.

Chemical-Induced Inhibition of Blue Light-Mediated Seedling Development Caused by Disruption of Upstream Signal Transduction Involving Cryptochromes in Arabidopsis thaliana.

Ong WD, Okubo-Kurihara E, Kurihara Y, Shimada S, Makita Y, Kawashima M, Honda K, Kondoh Y, Watanabe N, Osada H, Cutler SR, Sudesh K, Matsui M.

Plant Cell Physiol. 2017 Jan 1;58(1):95-105. doi: 10.1093/pcp/pcw181.

PMID:
28011868
36.

Nintedanib in Japanese patients with idiopathic pulmonary fibrosis: A subgroup analysis of the INPULSIS® randomized trials.

Azuma A, Taniguchi H, Inoue Y, Kondoh Y, Ogura T, Homma S, Fujimoto T, Sakamoto W, Sugiyama Y, Nukiwa T.

Respirology. 2017 May;22(4):750-757. doi: 10.1111/resp.12960. Epub 2016 Dec 20.

PMID:
27997064
37.

Soluble thrombomodulin in bronchoalveolar lavage fluid is an independent predictor of severe drug-induced lung injury.

Suzuki A, Taniguchi H, Kondoh Y, Ando M, Watanabe N, Kimura T, Kataoka K, Yokoyama T, Sakamoto K, Hasegawa Y.

Respirology. 2017 May;22(4):744-749. doi: 10.1111/resp.12965. Epub 2016 Dec 15.

PMID:
27976836
38.

COPD Assessment Test for measurement of health status in patients with idiopathic pulmonary fibrosis: A cross-sectional study.

Matsuda T, Taniguchi H, Ando M, Kondoh Y, Kimura T, Kataoka K, Sakamoto K, Suzuki A, Furukawa T, Hasegawa Y.

Respirology. 2017 May;22(4):721-727. doi: 10.1111/resp.12936. Epub 2016 Nov 9.

PMID:
27859913
39.

Nintedanib (OFEV) in the treatment of idiopathic pulmonary fibrosis.

Fukihara J, Kondoh Y.

Expert Rev Respir Med. 2016 Dec;10(12):1247-1254. Epub 2016 Oct 31. Review.

PMID:
27744713
40.

In vitro and in vivo evaluation of tissue-cultured mountain ginseng on penile erection.

Lee HS, Lee YJ, Chung YH, Lee MY, Kim ST, Ko SK, Momoi M, Kondoh Y, Sasaki F, Jeong JH.

J Ginseng Res. 2016 Oct;40(4):334-343. Epub 2015 Nov 2.

41.

Opposing roles for SNAP23 in secretion in exocrine and endocrine pancreatic cells.

Kunii M, Ohara-Imaizumi M, Takahashi N, Kobayashi M, Kawakami R, Kondoh Y, Shimizu T, Simizu S, Lin B, Nunomura K, Aoyagi K, Ohno M, Ohmuraya M, Sato T, Yoshimura SI, Sato K, Harada R, Kim YJ, Osada H, Nemoto T, Kasai H, Kitamura T, Nagamatsu S, Harada A.

J Cell Biol. 2016 Oct 10;215(1):121-138. Epub 2016 Oct 3.

42.

Interobserver Agreement of Usual Interstitial Pneumonia Diagnosis Correlated With Patient Outcome.

Hashisako M, Tanaka T, Terasaki Y, Uekusa T, Achcar RD, Aswad BI, Bamefleh HS, Capelozzi VL, English JC, Fabro AT, Kataoka K, Hayashi T, Kondoh Y, Taniguchi H, Fukuoka J.

Arch Pathol Lab Med. 2016 Dec;140(12):1375-1382. Epub 2016 Sep 9.

PMID:
27610646
43.

Validation of the Japanese disease severity classification and the GAP model in Japanese patients with idiopathic pulmonary fibrosis.

Kondoh S, Chiba H, Nishikiori H, Umeda Y, Kuronuma K, Otsuka M, Yamada G, Ohnishi H, Mori M, Kondoh Y, Taniguchi H, Homma S, Takahashi H.

Respir Investig. 2016 Sep;54(5):327-33. doi: 10.1016/j.resinv.2016.02.009. Epub 2016 Mar 30.

PMID:
27566380
44.

Allantopyrone A activates Keap1-Nrf2 pathway and protects PC12 cells from oxidative stress-induced cell death.

Uesugi S, Muroi M, Kondoh Y, Shiono Y, Osada H, Kimura KI.

J Antibiot (Tokyo). 2017 Apr;70(4):429-434. doi: 10.1038/ja.2016.99. Epub 2016 Aug 10.

PMID:
27507633
45.

Exercise hypoxaemia as a predictor of pulmonary hypertension in COPD patients without severe resting hypoxaemia.

Nakahara Y, Taniguchi H, Kimura T, Kondoh Y, Arizono S, Nishimura K, Sakamoto K, Ito S, Ando M, Hasegawa Y.

Respirology. 2017 Jan;22(1):120-125. doi: 10.1111/resp.12863. Epub 2016 Jul 28.

PMID:
27471142
46.

The COPD assessment test and St George's Respiratory Questionnaire: are they equivalent in subjects with COPD?

Morishita-Katsu M, Nishimura K, Taniguchi H, Kimura T, Kondoh Y, Kataoka K, Ogawa T, Watanabe F, Arizono S, Nishiyama O, Nakayasu K, Imaizumi K, Hasegawa Y.

Int J Chron Obstruct Pulmon Dis. 2016 Jul 7;11:1543-51. doi: 10.2147/COPD.S104947. eCollection 2016.

47.

Comparative chemical array screening for p38γ/δ MAPK inhibitors using a single gatekeeper residue difference between p38α/β and p38γ/δ.

Kondoh Y, Honda K, Hiranuma S, Hayashi T, Shimizu T, Watanabe N, Osada H.

Sci Rep. 2016 Jul 19;6:29881. doi: 10.1038/srep29881.

48.

Pulmonary alveolar proteinosis-like change: A fairly common reaction associated with the severity of idiopathic pulmonary fibrosis.

Nunomura S, Tanaka T, Nakayama T, Otani K, Ishii H, Tabata K, Kondoh Y, Kataoka K, Johkoh T, Taniguchi H, Fukuoka J.

Respir Investig. 2016 Jul;54(4):272-9. doi: 10.1016/j.resinv.2016.02.004. Epub 2016 Mar 30.

PMID:
27424827
49.

Acute respiratory distress syndrome due to severe pulmonary tuberculosis treated with extracorporeal membrane oxygenation: A case report and review of the literature.

Omote N, Kondoh Y, Taniguchi H, Kimura T, Kataoka K, Hasegawa R, Hasegawa Y.

Respir Med Case Rep. 2016 Jun 10;19:31-3. doi: 10.1016/j.rmcr.2016.06.001. eCollection 2016.

50.

Lung histopathological pattern in a survivor with rapidly progressive interstitial lung disease and anti-melanoma differentiation-associated gene 5 antibody-positive clinically amyopathic dermatomyositis.

Suzuki A, Kondoh Y, Taniguchi H, Tabata K, Kimura T, Kataoka K, Ono K, Hashisako M, Fukuoka J.

Respir Med Case Rep. 2016 May 28;19:5-8. doi: 10.1016/j.rmcr.2016.05.008. eCollection 2016.

Supplemental Content

Loading ...
Support Center